Lauren P. Carboni
Senior Counsel
Lauren Carboni advises a variety of clients in the health care, cannabis, and psychedelic industries on regulatory, compliance, litigation, and enforcement issues. She is a creative and solutions-oriented attorney, with an arsenal of legal strengths at her disposal. As both a regulatory attorney and litigator, Lauren brings a unique perspective to counseling clients with respect to business strategy, fraud and abuse protection, regulatory compliance matters, and investigation defense. She also co-chairs the Health Care & Life Sciences Sector’s Health Care Litigation Area of Focus.
Lauren’s health care experience includes regularly advising clients on a variety of complex federal and state regulatory requirements and strategies, including response to and compliance with investigations and audits undertaken by federal and state regulatory and enforcement agencies, as well as litigation (including False Claims Acts and administrative challenges). She also is well versed in issues related to the corporate practice of medicine and referral-source contracting. Lauren counsels clients in the cannabis and psychedelic industries on licensing, regulatory compliance, general business, and the intersection of state and federal law.
Lauren is active in the community and committed to providing pro bono services. She serves on the board of the Chanda Center for Health, a nonprofit health center that seeks to improve the quality of life for individuals with long-term physical disabilities by providing population-competent care.
Awards and Recognition
- Colorado Super Lawyers®– Rising Stars lists (2017–2020, 2022) which recognizes the top 2.5 percent of Colorado lawyers under 40 years of age
- 5280’s Denver’s Top Lawyers (2022)
- Trial Lawyer of the Year Finalist (2017), Public Justice, for representation of an incarcerated individual challenging his conditions of confinement and access to medical care
Affiliations
- Member, American Health Lawyers Association
- Member, Colorado Bar Association, Health Law Section
- Member, Colorado Women’s Bar Association
Publications and Presentations
- Co-author, “Substance Use Disorder Treatment Services: 2025 Physician Fee Schedule Proposed Rule Would Expand Access and Medicare Coverage,” Health Care Law Today (July 29, 2024)
- Co-author, “FDA Continues to Take Stance That it Will Not Issue CBD Rules,” Health Care Law Today (April 24, 2024)
- Co-author, “2023 Going Digital Health’s Behavioral Health Tech Conference: Key Investment Takeaways,” Health Care Law Today (November 27, 2023)
- Co-author, “Psychedelic Drugs – Easing the Regulatory Hurdles for Development,” Health Care Law Today (December 15, 2022)
- Co-author, “Top Ten Government Enforcement Updates for In-House Counsel in Health Care (United States),” Association of Corporate Counsel (December 6, 2022)
- Author, “Colorado Legalizes Therapeutic Psychedelics – Now What?,” Health Care Law Today (November 14, 2022)
- Author, “The Psychedelics Renaissance is Here – Colorado May Become the Second State in the Nation to Legalize Therapeutic Psychedelics,” Health Care Law Today (October 26, 2022)
- Co-author, “What To Know About the New Colorado False Claims Act,” Health Care Law Today (June 28, 2022)
- Co-author, “Cannabis Mid-Year Update 2022,” Foley & Lardner Webinar (June 6, 2022)
- Co-author, “Behavioral Health Trends for 2022,” Foley & Lardner Webinar (March 31, 2022)
- Co-author, “Compliance Issues in Hospital and Health System Sports Sponsorships,” Health Care Law Today (February 9, 2022)
- Co-author, “A Target on Telehealth: Government Action Against Telehealth Fraud in the Wake of COVID-19,” American Health Law Association (July 14, 2021)
- Co-author, “Latest Open Payments Data Released Under Heightened Government Scrutiny,” Health Care Law Today (July 9, 2021)
- Co-author, “The New Face of COVID-19 Fraud Enforcement: An Inter-Agency Task Force,” Coronavirus Resource Center: Back to Business (May 21, 2020)
- Co-author, “The City of Denver a Trendsetter in Cannabis Reform?,” Legal News: Cannabis Industry (April 26, 2021)
- Presenter, “Implications of a Repealed ACA,” Colorado State of Reform 2020 Teleconference (November 17, 2020)
- Co-author, “Government Seizure of Medical Supplies from Health Care Providers – Is It Legal?,” Coronavirus Resource Center: Back to Business (May 15, 2020)
- Presenter, “COVID-19 Provider Relief Funding Webinar,” Foley & Lardner Webinar (April 27, 2020)
- Co-author, “COVID-19: Understanding HHS’s Plans to Disperse Provider Relief Funds Authorized By The CARES Act,” Coronavirus Resource Center: Back to Business (April 27, 2020)
- Co-author, “COVID-19 Not Slowing Efforts to Update Denver’s Cannabis Rule,” Coronavirus Resource Center: Back to Business (April 21, 2020)
- Co-author, “COVID-19: “Hospitals Without Walls” and “Patients Over Paperwork” – Key Takeaways For Hospitals From CMS’ Additional Blanket Waivers,” Coronavirus Resource Center: Back to Business (April 6, 2020)
- Co-author, “COVID-19: Washington Becomes the Second State Approved for 1135 Medicaid Waiver – Key Takeaways,” Coronavirus Resource Center: Back to Business (March 23, 2020)
- Author, “Prime Healthcare Services and its CEO Agree to Pay $65 Million to Settle Fraud Claims: The Government Sends A Clear Message That It Takes Unnecessary Inpatient Stays and ‘Upcoding’ Seriously,” Journal of Health Care Compliance (November-December 2018)
- Co-author, “Work Product Immunity,” Discovery in Colorado (2017, 2018)
- Presenter, “Electronic Documents and E-Discovery: What the Colorado State Courts Are Saying,” Colorado Bar Association CLE (June 21, 2017)
- Co-author, “Managing Risks When Working with Experts and Consultants,” The Colorado Lawyer (June 2017)
- Co-author, “Attorney-Witnesses Face a Host of Hazards,” The Colorado Lawyer (November 18, 2016)
- Co-author, “New Approach To Pleading Standards From Colo. High Court,” Law360 (August 26, 2016)
- Author, “Litigation Update – Legal Recreational Marijuana,” American Bar Association (May 24, 2016)
Substance Use Disorder Treatment Services: 2025 Physician Fee Schedule Proposed Rule Would Expand Access and Medicare Coverage
FDA Continues to Take Stance That it Will Not Issue CBD Rules
Survey Enforcement Appeal Process
Foley Represents Parkview Health System in Combination with UCHealth
